Article
Genetic association of long-chain acyl-CoA synthetase 1 variants with fasting glucose, diabetes, and subclinical atherosclerosis.
Journal of lipid research - 1 Mar 2016
Manichaikul Ani, Wang Xin-Qun, Zhao Wei, Wojczynski Mary K, Siebenthall Kyle, Stamatoyannopoulos John A, Saleheen Danish, Borecki Ingrid B, Reilly Muredach P, Rich Stephen S, Bornfeldt Karin E
Abstract excerpt
Long-chain acyl-CoA synthetase 1 (ACSL1) converts free fatty acids into acyl-CoAs. Mouse studies have revealed that ACSL1 channels acyl-CoAs to β-oxidation, thereby reducing glucose utilization, and is required for diabetes-accelerated atherosclerosis. The role of ACSL1 in humans is unknown. We therefore examined common variants in the human ACSL1 locus by genetic association studies for fasting glucose, diabetes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
